HC Wainwright & Co. Reiterates Buy on Axsome Therapeuticsto Buy
HC Wainwright & Co. Reiterates Buy on Axsome Therapeuticsto Buy
HC Wainwright & Co. 重申買入Axsome Therapeutics
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Axsome Therapeutics (NASDAQ:AXSM) from Buy to Buy.
HC Wainwright & Co. 分析師Raghuram Selvaraju將Axsome Therapeutics（納斯達克:AXSM）從買入重申爲買入。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。